Wockhardt said on Wednesday that the state drug controller, Himachal Pradesh, has suspended the manufacture, sale or distribution of fixed dose combination (FDC) Dicyclomine Hydrochloride IP 10mg, Tramadol Hydrochloride IP 50mg & Acetamenophen IP 325mg.

"The company in order to revoke the said suspension is filing an appeal before the State Government under the provisions of applicable law," said Wockhardt.

"The product contributed less than 3% of the consolidated sales of Wockhardt during the financial year 2013-14," it added.

Shares of the company gained Rs 5.7, or 0.87%, to settle at Rs 660.05. The total volume of shares traded was 277,372 at the BSE (Wednesday).